H.R. 7658

To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

Latest
Raw Text PDF XML

I

117th CONGRESS

2d Session

H. R. 7658

IN THE HOUSE OF REPRESENTATIVES

May 3, 2022

Mr. O'Halleran (for himself and Mrs. Lesko) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

1.

Reauthorization of the Critical Path Public-Private Partnerships

Section 566(f) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb–5(f)) is amended by striking $6,000,000 for each of fiscal years 2018 through 2022 and inserting $10,000,000 for each of fiscal years 2023 through 2027.